![(S)-7-(5-Methyl-furan-2-yl)-3-[6-(tetrahydro-furan-3-yloxyMethyl)-pyridin-2-ylMethyl]-3H-[1,2,3]triazolo[4,5-d]pyriMidin-5-ylaMine structure, CAS 1202402-40-1](/structures/180000/166947_2_1202402_40_1.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1202402-40-1 |
| Catalog No. | 2A-1166931 |
| Chinese Name | CPI-444 |
| Synonyms | Target; Adenosine A2A receptor[1]; References |
| Molecular Formula | C20H21N7O3 |
| Molecular Weight | 407.43 |
| Storage Condition | 2-8℃ |
| Application | CPI-444 is a potent and selective A2A receptor (A2AR) inhibitor that induces anti-tumor responses. |
| PubChem ID | 87219378 |
| InChI | InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1 |
| InChI Key | KURQKNMKCGYWRJ-HNNXBMFYSA-N |
| Transport Info | Product name: Ciforadenant (CPI-444) |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid | 1012341-50-2 | 2A-1166855 |
| 4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE | 941685-27-4 | 2A-1166856 |
| 4-(N-BOC-aMinoMethyl)-2-BroMopyridine | 1049025-21-9 | 2A-1166885 |
| (R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-Methylpent-2-enoic acid | 1012341-48-8 | 2A-1166899 |
| N-Boc,(2R)-{[(1-(1,1-biphenyl)-4-yl]-2-amino-3-3-propanol | 1426129-50-1 | 2A-1166900 |
| (R)-N-(2-(4-isopropyl-4,5-dihydrooxazol-2-yl) – 6-methylphenyl)methane sulfonamide | 871360-40-6 | 2A-1166990 |
| (R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate | 219823-47-9 | 2A-1166991 |
| (R)-tert-butyldimethyl(3-(oxiran-2-yl)propoxy)silane | 197229-73-5 | 2A-1166993 |
| (S)-2-Amino-3-(3-(Methylsulfonyl)Phenyl)Propanoic Acid | 1270093-99-6 | 2A-1166999 |
| 2-(2-chloro-4-quinazolinyl)-9-phenyl-9H-Carbazole | 1616499-37-6 | 2A-1167031 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA